Natalia A. Trayanova,Adityo Prakosa,Mark Cartoski,Patrick M. Boyle
申请号：
US16347385
公开号：
US20200261028A1
申请日:
2017.11.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
An embodiment in accordance with the present invention provides a non-invasive solution to risk stratify the risk of in arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists. In the realm of congenital heart disease, cardiac MRI is now used routinely for patients with Tetralogy of Fallot (TOF), the most common form of cyanotic congenital heart disease. An innovative platform for using clinical MRI data to create 3D electromechanical models of the heart enables predictions of whether or not patients with ischemic heart disease have the substrate for arrhythmia and what their relative risk for such an event is. An embodiment of the current invention provides a non-invasive solution to risk stratify the risk of arrhythmia in patients with TOF. Currently, no reliable method for non-invasive risk stratification exists.
